Radiopharmacokinetic data for Tc-99m-ABP - A new radiopharmaceutical for bone scanning: Comparison with Tc-99m-MDP

被引:12
|
作者
deMurphy, CA
MelendezAlafort, L
MontoyaMolina, CE
SepulvedaMendez, J
机构
[1] Inst. Nac. de Nutr. Salvador Zubiran, México City
[2] Depto. Med. Nucl. y Clin. Tiroides, Inst. Nac. de Nutr. Salvador Zubiran, Delegación Tlalpan D.F. 1400
来源
NUCLEAR MEDICINE AND BIOLOGY | 1997年 / 24卷 / 01期
关键词
pharmacokinetics-radioactive-alendronate; Technetium-99mTc-alendronate-pharmacokinetics; diphosphonate-99mTc-ABP-pharmacokinetics; bone scan-99mTc-alendronate;
D O I
10.1016/S0969-8051(96)00151-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Technetium-99m-labeled alendronate is a new radiopharmaceutical for bone scanning developed under strict quality control at the INNSZ, The purpose of this work was to compare the radiopharmacokinetic data and the dosimetry of Tc-99m-ABP and Tc-99m-MDP in 10 volunteers, after it was tested in laboratory animals. Tc-99m-ABP has shorter mean residence time (MRT) and t(1/2) beta; is less protein bound; has a higher renal clearance; smaller Vdss, and similar bone uptake at 1 and 2 h. Tc-99m-ABP gives less radiation exposure to the patient with a 740 MBq dose, and the quality of the bone scan is excellent. Tc-99m-ABP is a better radiopharmaceutical than Tc-99m-MnP for bone scanning. Copyright (C) 1997 Elsevier Science Inc.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 50 条
  • [41] BONE-SCINTIGRAPHY WITH TC-99M-MDP IN LEGG-PERTHES DISEASE
    MUSSA, GC
    BONA, G
    SILVESTRO, L
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1985, 11 (05): : 547 - 547
  • [42] INCREASED UPTAKE OF TC-99M-MDP IN CALCIFIED SYNOVIAL SARCOMA
    HORNE, T
    MOGLE, P
    FINSTERBUSH, A
    GORDIN, M
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1983, 8 (02): : 75 - 76
  • [43] INTENSE MYOCARDIAL UPTAKE OF TC-99M-MDP IN A CASE OF HYPERCALCEMIA
    SEID, K
    LIN, D
    FLOWERS, WM
    CLINICAL NUCLEAR MEDICINE, 1981, 6 (12) : 565 - 567
  • [44] DIFFUSELY INCREASED TC-99M-MDP UPTAKE IN BOTH KIDNEYS
    KOIZUMI, K
    TONAMI, N
    HISADA, K
    CLINICAL NUCLEAR MEDICINE, 1981, 6 (08) : 362 - 365
  • [45] EFFECT OF ALUMINUM ON THE RADIOCHEMICAL PURITY AND TC-99M-MDP BIODISTRIBUTION
    JOVANOVIC, V
    JOVANOVIC, MS
    MAKSIN, T
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES, 1988, 122 (01): : 57 - 63
  • [46] TRANSIENT SPLENIC UPTAKE OF TC-99M-MDP ASSOCIATED WITH HEMOLYSIS
    ALEVIZAKI, CC
    GEORGIOU, E
    NIKIFORAKIS, E
    PROUKAKIS, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1982, 7 (11): : 510 - 512
  • [47] EVALUATION OF CHRONIC OSTEOMYELITIS IN-111 LABELED LEUKOCYTE, TC-99M NANOCOLLOID AND TC-99M-MDP SCINTIGRAPHIES
    BIANCHI, L
    DAMICO, P
    CELENTANO, L
    PERNA, E
    COZZOLINO, F
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1987, 31 (01): : 25 - 26
  • [48] RESPONSE OF TC-99M-MDP SCANNING AND WHOLE-BODY RETENTION TO INTRAVENOUS PAMIDRONATE
    HADDAWAY, MJ
    DAVIE, MWJ
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1994, 23 (04) : 280 - 280
  • [49] PROTEIN-BINDING AND URINARY-EXCRETION OF TC-9M(SN)-MDP AND TC-99M-MDP
    SAVELKOUL, TJF
    VANGINKEL, JJ
    GROULS, RJE
    OLDENBURG, SJ
    DUURSMA, SA
    INTERNATIONAL JOURNAL OF NUCLEAR MEDICINE & BIOLOGY, 1985, 12 (02): : 125 - &
  • [50] CLINICAL COMPARISON OF TC-99M HEDP AND TC-99M MDP IN THE DETECTION OF BONE METASTASES - CONCISE COMMUNICATION
    FOGELMAN, I
    CITRIN, DL
    MCKILLOP, JH
    TURNER, JG
    BESSENT, RG
    GREIG, WR
    JOURNAL OF NUCLEAR MEDICINE, 1979, 20 (02) : 98 - 101